Note: Ingredients listed on restricted chemical lists
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
100%
General Information
Version
2.05
Revision date
2018-04-07
Product name
JOHNSTONES PERFORMANCE Anti-Slip Additive
CAS No.
14808-60-7
1.2.1 Relevant identified uses
Consumer applications, Professional applications
Emergency telephone
+44 (0) 1924 354000, +44 (0) 1924 354533
Icons in SDS
Company Information
company name
PPG Architectural Coatings UK Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
ps.acemea-north@ppg.com
GHS Information
Signal word
No signal word
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mono-constituent substance
Signal word
No signal word.
Hazard statements
No known significant effects or critical hazards.
Precautionary statements
General : Keep out of reach of children. If medical advice is needed, have product container or label at hand.
Prevention
Not applicable.
Response
Not applicable.
Storage
Not applicable.
Disposal
Not applicable. P102, P101
Hazardous Ingredients
Quartz (SiO2)
Supplemental label elements
Not applicable.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Substance meets the criteria for PBT : Not applicable. Substance meets the criteria for vPvB : Not applicable.
Other hazards which do not result in classification
Handling and/or processing of this material may generate a dust which can cause mechanical irritation of the eyes, skin, nose and throat.
2.1 Classification of the substance or mixture
Product definition : Mono-constituent substance Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Not classified. The product is not classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
